Search research articles
Contact Us
Filters
Showing results (1-10 of 98) with videos related to
Page
of 10
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 12, 2013
Induction therapy for newly diagnosed multiple myeloma
Sagar Lonial, Jesus F San Miguel
Advances in Therapy
|
September 29, 2016
The Role of Panobinostat Plus Bortezomib and Dexamethasone in Treating Relapsed or Relapsed and Refractory Multiple Myeloma: A European Perspective
Jesus F San-Miguel, Hermann Einsele, Philippe Moreau
Cancer Cell
|
September 17, 2015
Engineering Anti-myeloma Responses Using Affinity-Enhanced TCR-Engineered T Cells
Jesus F San Miguel, Bruno Paiva, Juan-Jose Lasarte
Expert Opinion on Investigational Drugs
|
May 25, 2012
Novel agents derived from the currently approved treatments for MM: novel proteasome inhibitors and novel IMIDs
Enrique M Ocio, Maria-Victoria Mateos, Jesus F San-Miguel
European Journal of Haematology
|
October 15, 2010
Emerging therapies for the treatment of relapsed or refractory multiple myeloma
Meletios A Dimopoulos, Jesus F San-Miguel, Kenneth C Anderson
Blood
|
October 29, 2009
How I treat multiple myeloma in younger patients
A Keith Stewart, Paul G Richardson, Jesus F San-Miguel
Hematology (Amsterdam, Netherlands)
|
April 18, 2012
Multiple myeloma: treatment evolution
Jesus F San Miguel, Maria Victoria Mateos, Enrique Ocio, et al.
Hematology/Oncology Clinics of North America
|
September 13, 2014
Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma
Robert A Kyle, Jesus F San-Miguel, Maria-Victoria Mateos, et al.
World Journal of Stem Cells
|
August 16, 2014
Multiple myeloma mesenchymal stromal cells: Contribution to myeloma bone disease and therapeutics
Antonio Garcia-Gomez, Fermin Sanchez-Guijo, M Consuelo Del Cañizo, et al.
British Journal of Haematology
|
October 3, 2002
Influence of the different CD34+ and CD34- cell subsets infused on clinical outcome after non-myeloablative allogeneic peripheral blood transplantation from human leucocyte antigen-identical sibling donors
Pablo Menéndez, Jose A Pérez-Simón, Maria V Mateos, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 98) with videos related to
Sort By:
Page
of 10
Journal of the National Comprehensive Cancer Network : JNCCN
|
January 12, 2013
Induction therapy for newly diagnosed multiple myeloma
Sagar Lonial, Jesus F San Miguel
Advances in Therapy
|
September 29, 2016
The Role of Panobinostat Plus Bortezomib and Dexamethasone in Treating Relapsed or Relapsed and Refractory Multiple Myeloma: A European Perspective
Jesus F San-Miguel, Hermann Einsele, Philippe Moreau
Cancer Cell
|
September 17, 2015
Engineering Anti-myeloma Responses Using Affinity-Enhanced TCR-Engineered T Cells
Jesus F San Miguel, Bruno Paiva, Juan-Jose Lasarte
Expert Opinion on Investigational Drugs
|
May 25, 2012
Novel agents derived from the currently approved treatments for MM: novel proteasome inhibitors and novel IMIDs
Enrique M Ocio, Maria-Victoria Mateos, Jesus F San-Miguel
European Journal of Haematology
|
October 15, 2010
Emerging therapies for the treatment of relapsed or refractory multiple myeloma
Meletios A Dimopoulos, Jesus F San-Miguel, Kenneth C Anderson
Blood
|
October 29, 2009
How I treat multiple myeloma in younger patients
A Keith Stewart, Paul G Richardson, Jesus F San-Miguel
Hematology (Amsterdam, Netherlands)
|
April 18, 2012
Multiple myeloma: treatment evolution
Jesus F San Miguel, Maria Victoria Mateos, Enrique Ocio, et al.
Hematology/Oncology Clinics of North America
|
September 13, 2014
Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma
Robert A Kyle, Jesus F San-Miguel, Maria-Victoria Mateos, et al.
World Journal of Stem Cells
|
August 16, 2014
Multiple myeloma mesenchymal stromal cells: Contribution to myeloma bone disease and therapeutics
Antonio Garcia-Gomez, Fermin Sanchez-Guijo, M Consuelo Del Cañizo, et al.
British Journal of Haematology
|
October 3, 2002
Influence of the different CD34+ and CD34- cell subsets infused on clinical outcome after non-myeloablative allogeneic peripheral blood transplantation from human leucocyte antigen-identical sibling donors
Pablo Menéndez, Jose A Pérez-Simón, Maria V Mateos, et al.
Page
of 10